Discover

CMRX
Chimerix, Inc.
8.54
undefined x undefined
undefined x undefined
bid
ask
+
0.00
0.00%
04:00 PM
Ytd145.40%
1y844.69%
8.54
day range
8.54
52 week range
Open8.54Prev Close8.54Low8.54High8.54Mkt Cap271.61M
Vol2.55MAvg Vol0.00EPSN/AP/EN/AForward P/E-2.93
Beta1.13Short Ratio2.44Inst. Own45.90%DividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d AvgN/A200-d AvgN/A1yr Est8.40

CMRX News

Jazz Pharmaceuticals Completes Acquisition of Chimerix
prnewswire.com
Jazz Pharmaceuticals Completes Acquisition of Chimerix

- Addition of dordaviprone strengthens Jazz's late-stage oncology pipeline and reinforces commitment

Top 3 Health Care Stocks That May Crash In Q2
benzinga.com
Top 3 Health Care Stocks That May Crash In Q2

Biotech Stocks Q1 2025 Recap: Winners And Underperformers
seekingalpha.com
Biotech Stocks Q1 2025 Recap: Winners And Underperformers

Investing in biotech can be highly rewarding but is fraught with risks; understanding past catalysts

Chimerix Reports Fourth Quarter and Year End 2024 Financial Results
globenewswire.com
Chimerix Reports Fourth Quarter and Year End 2024 Financial Results

New Drug Application (NDA) for Dordaviprone as Treatment for Recurrent H3 K27M-Mutant Diffuse Glioma

CHIMERIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chimerix, Inc. - CMRX
businesswire.com
CHIMERIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investig

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

DURHAM, N.C., March 07, 2025 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on Mar

CMRX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Chimerix, Inc. is Fair to Shareholders
globenewswire.com
CMRX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Chimerix, Inc. is Fair to Sh

NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is inves

The Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals
zacks.com
The Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals

Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals are included in this Anal

Biotech Stocks Roundup: CMRX Up on JAZZ Bid, MRNA Up on Updates & More
zacks.com
Biotech Stocks Roundup: CMRX Up on JAZZ Bid, MRNA Up on Updates & More

CMRX and JAZZ are in the spotlight this week following an acquisition agreement.

Jazz Offers to Buy Chimerix for $935M to Boost Oncology Portfolio
zacks.com
Jazz Offers to Buy Chimerix for $935M to Boost Oncology Portfolio

JAZZ's acquisition of CMRX is set to add a rare high-grade brain tumor drug currently under the FDA'

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Chimerix, Inc. - CMRX
prnewswire.com
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Chimerix, Inc. - CMRX

NEW YORK , March 5, 2025 /PRNewswire/ -- Monteverde & Associates PC  (the "M&A Class Action Firm"),

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CMRX and GLYC on Behalf of Shareholders
prnewswire.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CMRX and GLYC on Behalf of Shareholders

NEW YORK , March 5, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investiga

Jazz Pharma To Buy Chimerix For $935 Million, Strengthening Rare Cancer Pipeline
benzinga.com
Jazz Pharma To Buy Chimerix For $935 Million, Strengthening Rare Cancer Pipeline

On Tuesday, Jazz Pharmaceuticals plc JAZZ agreed to acquire Chimerix Inc CMRX for $8.55 per share in

Jazz Pharmaceuticals to buy Chimerix for $935 million
reuters.com
Jazz Pharmaceuticals to buy Chimerix for $935 million

Jazz Pharmaceuticals will acquire biotech firm Chimerix for about $935 million to gain access to its

Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
prnewswire.com
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio

-Dordaviprone addresses a significant unmet patient need for patients with rare, high-grade brain tu

Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
globenewswire.com
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio

-Dordaviprone addresses a significant unmet patient need for patients with rare, high-grade brain tu

Chimerix: Potential 'First' In Targeting Recurrent High-Grade Glioma Patients
seekingalpha.com
Chimerix: Potential 'First' In Targeting Recurrent High-Grade Glioma Patients

The company holds potential to have first approval of dordaviprone for the treatment of recurrent H3

Here's Why Momentum in Chimerix (CMRX) Should Keep going
zacks.com
Here's Why Momentum in Chimerix (CMRX) Should Keep going

Chimerix (CMRX) made it through our "Recent Price Strength" screen and could be a great choice for i

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

DURHAM, N.C., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on Febr

CMRX Stock Skyrockets in 3 Months: Here's What You Should Know
zacks.com
CMRX Stock Skyrockets in 3 Months: Here's What You Should Know

Chimerix stock surges 324% in three months following NDA submission for high-grade glioma drug, dord

Chimerix to Present at JonesTrading Virtual Precision Medicine Symposium
globenewswire.com
Chimerix to Present at JonesTrading Virtual Precision Medicine Symposium

DURHAM, N.C., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company

benzinga.com
Earnings Scheduled For February 29, 2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings

benzinga.com
Earnings Scheduled For November 2, 2023

Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly ear

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  During the Friday's sesion, 157 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  On Wednesday, 155 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  During Tuesday's trading, 188 companies set new 52-week lows.

benzinga.com
Earnings Scheduled For August 3, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  During Wednesday's session, 117 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 164 companies hit new 52-week lows.

benzinga.com
Earnings Scheduled For May 4, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss a

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  On Thursday, 185 companies achieved new lows for the year.

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  On Wednesday, 345 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  Tuesday's session saw 286 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  On Wednesday, 81 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday, 469 companies hit new 52-week lows.

benzinga.com
Earnings Scheduled For March 2, 2023

Companies Reporting Before The Bell • argenx (NASDAQ:ARGX) is expected to report quarterly loss at

benzinga.com
Earnings Scheduled For November 3, 2022

Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnin

benzinga.com
Earnings Scheduled For August 8, 2022

  Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings fo

benzinga.com
Why Energy Stocks Traded Higher; Here Are 61 Biggest Movers From Yesterday

Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) jumped 150.4% to close at $1.59 on Monday after declini

benzinga.com
Why Is Infrastructure and Energy Alternatives Higher By Around 29%? 37 Stocks Moving In Monday's Mid

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 104% to $1.3263 after the company anno

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 951 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  During Monday's trading, 1214 companies set new 52-week lows.

benzinga.com
71 Biggest Movers From Yesterday

Gainers CynergisTek, Inc. (NYSE: CTEK) shares surged 100% to close at $1.18 on Tuesday after the

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 123 stocks made new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  On Monday, 198 companies reached new 52-week lows.

benzinga.com
Earnings Scheduled For May 16, 2022

  Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to repor

benzinga.com
Earnings Scheduled For November 4, 2021

  Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly e

benzinga.com
Earnings Scheduled For August 5, 2021

  Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report q

benzinga.com
Earnings Scheduled For May 6, 2021

  Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly e

benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2021